Abstract 6606: Develop dual-targeted CAR-T cells to achieve RCC curesYufei Wang, Wayne A. Marasco, Marion Grimaud et al.|Cancer Research|2020Cited by 3
Abstract 62: Development of dual-targeted fine-tuned immune restoring (DFIR) CAR T cell therapy for clear cell renal cell carcinoma (ccRCC)Yufei Wang, Wayne A. Marasco, Matthew Chang et al.|Cancer Research|2021Cited by 3
Abstract 3179: Design and activity of 2nd generation, dual-targeted CAR T cell factories against ccRCCYufei Wang, Wayne A. Marasco, Matthew Chang et al.|Cancer Research|2019Cited by 2